Literature DB >> 16938753

End-tidal carbon monoxide measurements in infant respiratory distress syndrome.

Tannette G Krediet1, Geert A Cirkel, Hendrik J Vreman, Ronald J Wong, David K Stevenson, Floris Groenendaal, Johannes Egberts, Frank Van Bel.   

Abstract

BACKGROUND: RDS involving inflammatory and oxidative processes may lead to increased production of carbon monoxide (CO). AIM: The relationship between end-tidal CO, corrected for inhaled CO (ETCOc), and RDS severity was investigated in preterm infants as well as the value of early ETCOc measurements to predict chronic lung disease.
METHODS: 78 infants (30 no RDS, 32 moderate RDS, 16 severe RDS) were included. ETCOc was measured using the CO-Stat End Tidal Breath Analyzer.
RESULTS: ETCOc was significantly higher in RDS compared to no RDS during the first week (p<0.05). Severity of RDS was the most significant independent variable in a stepwise regression model related to ETCOc (F-test: 18.17). Negative predictive value of early (within first 12 h of life) ETCOc measurement (<2.5 ppm) for development of chronic lung disease was excellent (100%).
CONCLUSION: During severe RDS, inflammation may contribute to increased lipid peroxidation leading to increased local CO production in the lung, indicated by increased ETCOc. Early ETCOc determinations may be helpful to exclude occurrence of chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938753     DOI: 10.1080/08035250500537017

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3 years 6 months of age in preterm infants.

Authors:  Cornelie A Blok; Tannette G Krediet; Annemiek Kavelaars; Corine Koopman-Esseboom; Hendrik J Vreman; Frank Van Bel
Journal:  Dev Med Child Neurol       Date:  2011-09-20       Impact factor: 5.449

Review 2.  Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review.

Authors:  Zhi-Qun Zhang; Xian-Mei Huang; Hui Lu
Journal:  Eur J Pediatr       Date:  2013-09-01       Impact factor: 3.183

3.  Increased heme oxygenase-1 expression in premature infants with respiratory distress syndrome.

Authors:  Ildikó Farkas; Zoltán Maróti; Márta Katona; Emoke Endreffy; Péter Monostori; Krisztina Máder; Sándor Túri
Journal:  Eur J Pediatr       Date:  2008-02-27       Impact factor: 3.183

4.  Amperometric Microsensors Monitoring Glutamate-Evoked In Situ Responses of Nitric Oxide and Carbon Monoxide from Live Human Neuroblastoma Cells.

Authors:  Yejin Ha; Chaejeong Heo; Juhyun Woo; Hyunwoo Ryu; Youngmi Lee; And Minah Suh
Journal:  Sensors (Basel)       Date:  2017-07-19       Impact factor: 3.576

5.  Oxidative Stress and Anti-Oxidant Markers in Premature Infants with Respiratory Distress Syndrome.

Authors:  Enas R Abdel Hamid; Walaa H Ali; Ashraf Azmy; Hanaa H Ahmed; Lobna S Sherif; Maysa T Saleh
Journal:  Open Access Maced J Med Sci       Date:  2019-08-30

6.  Exhaled carbon monoxide levels in infants and toddlers with episodic asthma.

Authors:  Yoichiro Ohara; Takahiro Ohara; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2020-06-27

7.  A novel approach to study oxidative stress in neonatal respiratory distress syndrome.

Authors:  Reena Negi; Deepti Pande; Kanchan Karki; Ashok Kumar; Ranjana S Khanna; Hari D Khanna
Journal:  BBA Clin       Date:  2014-12-08

8.  Unmyelinated white matter loss in the preterm brain is associated with early increased levels of end-tidal carbon monoxide.

Authors:  Cornelie A Blok; Karina J Kersbergen; Niek E van der Aa; Britt J van Kooij; Petronella Anbeek; Ivana Isgum; Linda S de Vries; Tannette G Krediet; Floris Groenendaal; Hendrik J Vreman; Frank van Bel; Manon J Benders
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 9.  Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant.

Authors:  Lidys Rivera; Roopa Siddaiah; Christiana Oji-Mmuo; Gabriela R Silveyra; Patricia Silveyra
Journal:  Front Pediatr       Date:  2016-03-31       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.